Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN

Delayed Quote. Delayed  - 02/09 12:44:00 pm
372.3517 USD   -4.65%
11:35a Wall St. flat as tech rebound offsets energy, financials
09:22aDJU.S. HOT STOCKS : Hot Stocks to Watch
07:56aDJRegeneron Reports Slowing Sales Growth for Key Eye Drug
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Wall St. flat as tech rebound offsets energy, financials

02/09/2016 | 11:35am US/Eastern
Traders work on the floor of the NYSE

(Reuters) - Wall Street bounced between gains and losses in choppy trading on Tuesday, as a decline in energy and financial sectors offset gains in materials and technology stocks.

Four of the 10 major S&P sectors were lower, with energy <.SPNY> down 1.7 percent and financials <.SPSY> off 0.43 percent.

The financial sector has taken the biggest beating this year, falling 15 percent, as recession fears compounded concern about their exposure to the energy sector and expectations that global interest rates are unlikely to rise quickly.

"We're starting to feel some of the knock on effects from energy and distress in those markets," said Steven Baffico, chief executive officer at Four Wood Capital Partners in New York.

"Over the last couple of days, that's spread into the financial system. It's difficult to find a lot of momentum to the upside for any sustained period of time," he said.

U.S. stocks have struggled for the better part of this year, and fell sharply in the previous two sessions, on increasing worries of a sustained slowdown in global economic growth and falling oil prices.

Brent crude oil prices were down 2 percent, giving up earlier gains.

At 11:29 a.m. ET, the Dow Jones industrial average <.DJI> was up 6.37 points, or 0.04 percent, at 16,033.42.

The S&P 500 <.SPX> was up 2.49 points, or 0.13 percent, at 1,855.93. The index is down 13.18 percent from its record high in May through Monday's close.

The Nasdaq Composite index <.IXIC> was up 9.60 points, or 0.22 percent, at 4,293.35. The index has slid 18.12 percent from its record in July through Monday's close.

The technology sector <.SPLRCT> was up 0.36 percent. Facebook (>> Facebook Inc) and Alphabet (>> Alphabet Inc) were up about 1.5 percent. Microsoft (>> Microsoft Corporation) was up 0.6 percent.

The stocks, which led the rout in technology stocks in the past two days, were propping up the S&P and the Nasdaq.

Viacom (>> Viacom, Inc.) tumbled 12.5 percent and Twenty-First Century Fox (>> Twenty-First Century Fox Inc) dropped 2.3 percent after the two media companies posted lower-than-expected revenue.

Other media stocks also fell. Disney (>> Walt Disney Co), scheduled to report after the close, was off nearly 1 percent. Investors are keen to know ESPN subscriber trends.

Regeneron Pharma (>> Regeneron Pharmaceuticals Inc) dipped 4.6 percent to $372.58 on a disappointing profit and a forecast of slowing sales growth for its blockbuster eye drug.

Declining issues outnumbered advancing ones on the NYSE by 2,282 to 640. On the Nasdaq, 1,741 issues fell and 835 advanced.

The S&P 500 index showed two new 52-week highs and 72 new lows, while the Nasdaq recorded three new highs and 303 lows.

(Reporting by Aastha Agnihotri and Abhiram Nandakumar in Bengaluru; Editing by Savio D'Souza)

By Abhiram Nandakumar

React to this article
Latest news on REGENERON PHARMACEUTICALS
11:35a Wall St. flat as tech rebound offsets energy, financials
09:22aDJU.S. HOT STOCKS : Hot Stocks to Watch
07:56aDJRegeneron Reports Slowing Sales Growth for Key Eye Drug
07:35a REGENERON PHARMACEUTICALS : Results of Operations and Financial Condition, Finan..
06:55a REGENERON PHARMACEUTICALS : misses Street 4Q forecasts
06:32a REGENERON PHARMACEUTICALS : Reports Fourth Quarter and Full Year 2015 Financial ..
02/08 UK cost agency rebuffs Sanofi cholesterol drug but backs Amgen's
02/02 REGENERON PHARMACEUTICALS : Amendments to Articles of Inc. or Bylaws; Change in ..
02/02 REGENERON PHARMACEUTICALS : Announces Upcoming 2016 Investor Conference Presenta..
01/28DJAmgen Profit Rises 39%; 2016 Outlook Raised
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials